Subscribe to RSS

DOI: 10.1055/s-0045-1812873
Alpha-Lipoic Acid (ALA)-Related Insulin Autoimmune Syndrome
Authors
Funding and Sponsorship This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Abstract
Insulin autoimmune syndrome (IAS) is a rare cause of hypoglycemia characterized by autoantibodies against endogenous insulin, often triggered by sulfhydryl-containing compounds such as alpha-lipoic acid (ALA). We report the case of a 43-year-old previously healthy woman who presented with recurrent fasting and postprandial hypoglycemia. Biochemical evaluation revealed inappropriately elevated insulin and C-peptide levels with negative sulfonylurea screen and no pancreatic lesion on imaging. Further history uncovered recent use of ALA, and markedly elevated insulin autoantibodies confirmed the diagnosis of ALA-induced IAS. Discontinuation of the supplement and dietary modification led to complete resolution of symptoms. This case highlights the importance of considering IAS in the differential diagnosis of unexplained hypoglycemia and underscores the need for detailed medication and supplement history.
Keywords
insulin autoimmune syndrome - hypoglycemia - alpha-lipoic acid - insulin autoantibodies - drug-induced autoimmunityPatient Consent Statement
Informed consent was obtained from the patient for publication of this case report.
Authors' Contributions
All authors were involved in data collection, manuscript drafting, and finalizing. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Compliance with Ethical Principles
No ethical approval is required for single case report.
Availability of Data and Material
For confidentiality reasons, the original data cannot be shared. However, all results are presented in this manuscript.
Publication History
Article published online:
31 October 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cappellani D, Macchia E, Falorni A, Marchetti P. Insulin autoimmune syndrome (Hirata Disease): a comprehensive review fifty years after its first description. Diabetes Metab Syndr Obes 2020; 13: 963-978
- 2 Uchigata Y, Eguchi Y, Takayama-Hasumi S, Omori Y. Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. Diabetes Res Clin Pract 1994; 22 (2-3): 89-94
- 3 Chang HJ, Choi HS, Park MY. et al. A case of insulin autoimmune syndrome related to alpha-lipoic acid. Korean J Med 2009; 76 (05) 600-604
- 4 Sehgal T, Ohri U, Mittal N, Attri P, Dishant F. A case of insulin autoimmune syndrome in an Indian male taking alpha-lipoic acid. Cureus 2023; 15 (08) e43743
- 5 Subramaniam K, Tom B. Autoimmune hypoglycemia due to alpha-lipoic acid: report of two cases. J Postgrad Med 2025; 71 (02) 95-97
- 6 Ismail AAA. The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis. Clin Chem Lab Med 2016; 54 (11) 1715-1724
- 7 Yao D, Jiang J, Zhou Q. et al. HLA alleles associate with insulin autoimmune syndrome. Diabetes Metab Syndr Obes 2024; 17: 3463-3475
- 8 Zhang H, Yuan MX, Pan Q. Insulin autoimmune syndrome: a Chinese expert consensus statement. Aging Med (Milton) 2025; 8 (01) e70007
- 9 Li Z, Su Y, Yi D, Wu C, Fang W, Wang C. Analysis of the clinical characteristics of insulin autoimmune syndrome induced by alpha-lipoic acid. J Clin Pharm Ther 2021; 46 (05) 1295-1300
- 10 Bresciani E, Bussi A, Bazzigaluppi E, Balestrieri G. Insulin autoimmune syndrome induced by α-lipoic acid in a Caucasian woman: case report. Diabetes Care 2011; 34 (09) e146
- 11 Cappellani D, Sardella C, Campopiano MC, Falorni A, Marchetti P, Macchia E. Spontaneously remitting insulin autoimmune syndrome in a patient taking alpha-lipoic acid. Endocrinol Diabetes Metab Case Rep 2018; 2018: 18-0122
